Table 1.
Correlations of JAB1 expression with the clinicopathological characteristics in 124 FFPe tissues of ESCC patients
| JAB1 | ||||
|---|---|---|---|---|
| Parameters | Cases | Overexpression (n = 65) | Low expression (n = 59) | P‐value |
| Age (years) | 0.491 | |||
| ≥50 | 102 | 55 | 47 | |
| <50 | 22 | 10 | 12 | |
| Gender | 0.523 | |||
| Female | 28 | 13 | 15 | |
| Male | 96 | 52 | 44 | |
| Tumor size (cm) | 0.150 | |||
| ≥3 | 64 | 38 | 26 | |
| <3 | 60 | 27 | 33 | |
| T status | 0.047 | |||
| T1–2 | 59 | 25 | 34 | |
| T3–4 | 65 | 40 | 25 | |
| N status | 0.050 | |||
| N0 | 64 | 28 | 36 | |
| N1‐2 | 60 | 37 | 23 | |
| Differentiation degree | 0.587 | |||
| Poor | 52 | 23 | 29 | |
| Moderate‐well | 72 | 36 | 36 | |
ESCC, esophageal squamous cell carcinoma; FFPe, formalin‐fixed paraffin‐embedded.